Literature DB >> 19604490

Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.

Marco Colonna1.   

Abstract

Blood, lymphoid tissues, and placenta contain diverse subpopulations of natural killer (NK) cells that possess distinct immune functions. Recent studies have shown that human and mouse gut-associated lymphoid tissues harbor a unique NK cell subset that specializes in production of interleukin (IL)-22. This cytokine plays a role in host defense of mucosal barriers, although dysregulated secretion may cause autoimmune disease. In parallel, human fetal lymphoid tissue inducer (LTi) cells and mouse adult LTi-like cells in secondary lymphoid tissues were found to release IL-22, as well as IL-17, a proinflammatory cytokine that mediates host defense against extracellular pathogens. Here, we compare these recently identified immune cells, reviewing what is known about their anatomical location, differentiation requirements, function, and potential involvement in host defense and autoimmunity. Finally, we discuss the challenges faced in furthering our understanding of the developmental relationships and role of NK and LTi-like cells in mucosal immune responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19604490     DOI: 10.1016/j.immuni.2009.06.008

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  147 in total

Review 1.  Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity.

Authors:  Peter J Morrison; Sarah J Ballantyne; Marika C Kullberg
Journal:  Immunology       Date:  2011-06-02       Impact factor: 7.397

2.  A role for interleukin-22 in the alleviation of metabolic syndrome.

Authors:  Elise Dalmas; Marc Y Donath
Journal:  Nat Med       Date:  2014-11-02       Impact factor: 53.440

3.  Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Authors:  Christophe Paget; Stoyan Ivanov; Josette Fontaine; Joelle Renneson; Fany Blanc; Muriel Pichavant; Laure Dumoutier; Bernhard Ryffel; Jean Christophe Renauld; Philippe Gosset; Pierre Gosset; Mustapha Si-Tahar; Christelle Faveeuw; François Trottein
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

Review 4.  New insights into the development of lymphoid tissues.

Authors:  Serge A van de Pavert; Reina E Mebius
Journal:  Nat Rev Immunol       Date:  2010-08-13       Impact factor: 53.106

5.  Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity.

Authors:  Marina Cella; Karel Otero; Marco Colonna
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

6.  Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection.

Authors:  Hailong Guo; David J Topham
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 7.  IL-17 family member cytokines: regulation and function in innate immunity.

Authors:  Joseph M Reynolds; Pornpimon Angkasekwinai; Chen Dong
Journal:  Cytokine Growth Factor Rev       Date:  2010-11-11       Impact factor: 7.638

Review 8.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection.

Authors:  Michelle L Manni; Keven M Robinson; John F Alcorn
Journal:  Expert Rev Respir Med       Date:  2013-12-10       Impact factor: 3.772

9.  Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells.

Authors:  Yong-Oon Ahn; Bruce R Blazar; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2013-01-17       Impact factor: 22.113

Review 10.  A Molecular Link Between Interleukin 22 and Intestinal Mucosal Wound Healing.

Authors:  Xiaoyan Sun; Laura Chalmers; Xiaobing Fu; Min Zhao
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-12       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.